StratDeck

Two stocks in Healthcare

Fresenius SE & Co. KGaA vs Lonza Group: profit, growth, debt and price compared

Fresenius SE & Co. KGaA is stronger on 5 of 7 figures: profit margin, price for its expected profit, dividend, analysts' view and price trend. Lonza Group is stronger on 2: sales growth and debt.

Figures as of 18 November 2026Yahoo Finance
Explore Fresenius SE & Co. KGaA's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Fresenius SE & Co. KGaA and Lonza Group side by side
Fresenius SE & Co. KGaAFRE.DELonza GroupLONN.SW
Net marginStronger: 6.6%−1.6%
Revenue growth, past year+5.90%Stronger: +11.20%
Debt to equity57.0%Stronger: 51.1%
Forward P/EStronger: 13.7×29.7×
Dividend yieldStronger: 1.95%0.75%
AnalystsStronger: Strong buy · 14Buy · 23
From its 200-day averageStronger: +19.2%+17.8%

Share price over the past year

  • Fresenius SE & Co. KGaA+14.2%
  • Lonza Group+25.8%

20 Nov 202518 Nov 2026

Fresenius SE & Co. KGaA or Lonza Group: which is stronger?

  • FRE.DE

    Which is more profitable?

    Fresenius SE & Co. KGaA keeps more of each sale as profit: 6.6% against −1.6%.

  • LONN.SW

    Which is growing its sales faster?

    Lonza Group is growing its sales faster: +11.20% over the past year, against +5.90%.

  • LONN.SW

    Which has borrowed less?

    Lonza Group has borrowed less: its debt is 51.1% of what its shareholders own, against 57.0% for Fresenius SE & Co. KGaA.

  • FRE.DE

    Which costs less for the profit it is expected to make?

    Fresenius SE & Co. KGaA costs less for the profit it is expected to make: 13.7× its forward earnings, against 29.7×.

  • FRE.DE

    Which pays more in dividends?

    Fresenius SE & Co. KGaA pays more back in dividends for what a share costs: 1.95% a year, against 0.75%.

  • FRE.DE

    Which do analysts rate higher?

    Analysts are warmer on Fresenius SE & Co. KGaA: Strong buy, against Buy for Lonza Group.

  • FRE.DE

    Which is in the stronger price trend?

    Fresenius SE & Co. KGaA's price is in the stronger trend: 19.2% above its 200-day average, against 17.8% above.

What each company does

FRE.DEFresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa.

Reports results on 24 February 2027

LONN.SWLonza Group

Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, and internationally.

Reports results on 27 January 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every European healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.